Method and Composition for Administering Bioactive Compounds Derived from ...

1. A method of treating inflammation in a mammal, which comprises:

acquiring Morinda citrifolia leaves;

dissolves cutting the leaves into small pieces;

placing the leaves into a crushing device;

crushing the leaves;

percolating the leaf pieces in an alcohol solution;

collecting the alcohol and all alcohol soluble ingredients from the alcohol leaf slurry;

allowing the alcohol to evaporate;

leaving a primary leaf extract;

dissolving the leaf extract in water; and

administering to said diluted leaf extract mammal a compound containing an effective amount of a processed Morinda citrifolia leaf product wherein said compound decreases or prevents inflammation and/or pain.

2. The method of claim 1, wherein the leaf extract is dissolved in water to dilute the solution by an amount selected from a list consisting of:

10,000 milligrams per milliliter, 1000 milligrams per milliliter 100 milligrams per milliliter, 10 milligrams per milliliter, 1 milligram per milliliter, 0.1 milligrams per milliliter, 0.001 milligrams per milliliter, and 0.0001 milligrams per milliliter.

3. The method of claim 1, wherein the primary leaf extract is pasteurized.

4. The method of claim 1, wherein the primary leaf extract is partially sterilized.

5. The method of claim 1, further comprising a step of placing the primary leaf extract in a centrifuge to remove any remaining leaf juice and other materials, including chlorophyll.

6. The method of claim 1, wherein the primary leaf extract is further fractionated into a fraction selected from a list consisting of:

a dry hexane fraction; and

an aqueous methanol fraction hexane.

7. The method of claim 6, wherein the secondary fractions are produced utilizing a gas chromatograph containing silicone dioxide.

8. The method of claim 6, further comprising the steps of dividing the secondary methanol fraction into additional methanol fractions.

9. The method of claim 6, wherein the secondary hexane fraction is further fractionated into additional hexane fractions.

10. The method of claim 1, further comprising a step of combining the leaf extract with the fruit juice of the fruit of the Morinda citrifolia plant to obtain a leaf and serum.

11. The method of claim 2, further comprising the step of combining the primary extract with a carrier medium prior to administration.

12. The method of claim 1, wherein Cyclooxygenase-2 is also selectively inhibited, relative to Cyclooxygenase-1.

13. The method of claim 1, wherein the decreasing or prevention of inflammation and/or pain is accomplished while maintaining gastric mucosal integrity.

14. The method of claim 1, further comprising the step of diluting the dissolved extract by 100-fold prior to administration.

15. A method for promoting health comprising the steps of:

adding a processed Morinda citrifolia component to an alcohol-based solution;

isolating and extracting an active ingredient of said processed Morinda citrifolia component from said solution to obtain a fraction;

introducing said extracted active ingredient into said mammal, wherein said extracted active ingredient decreases or prevents inflammation and/or pain.

16. The method of claim 15, wherein said alcohol-based solution is selected from the group consisting essentially of methanol, ethanol, and ethyl acetate, and other alcohol-based derivatives.

17. The method of claim 1, wherein said active ingredient is selected from a list consisting of Pyro-phorbide a, Pheoporbide a, Purpin 7, and Pheophorbide Phytolester.

18. A method of treating inflammation in a mammal, which comprises:

acquiring Morinda citrifolia leaves;

dissolves cutting the leaves into small pieces;

placing the leaves into a crushing device;

crushing the leaves;

collecting all from the leaves as they are crushed;

dissolving the leaf juice in water; and

administering to said diluted leaf juice to a mammal, wherein said compound decreases or prevents inflammation and/or pain.

19. The method of claim 18, wherein the leaf extract is dissolved in water to dilute the solution by an amount selected from a list consisting of:

10,000 milligrams per milliliter, 1000 milligrams per milliliter 100 milligrams per milliliter, 10 milligrams per milliliter, 1 milligram per milliliter, 0.1 milligrams per milliliter, 0.001 milligrams per milliliter, and 0.0001 milligrams per milliliter.

20. The method of claim 18, wherein the leaf juice is further processed according to a method selected from a list consisting of: pasteurization, sterilization and partial sterilization.

21. The method of claim 18, wherein leaf juice is further fractionated into a fraction selected from a list consisting of:

a dry hexane fraction; and

an aqueous methanol fraction hexane.

22. The method of claim 21, further comprising the steps of dividing the secondary methanol fraction into additional methanol fractions.

23. The method of claim 21, wherein the secondary hexane fraction is further fractionated into additional hexane fractions.

24. The method of claim 18, further comprising a step of combining the leaf juice with the fruit juice of the fruit of the Morinda citrifolia plant to obtain a leaf and serum.

25. The method of claim 18, further comprising the step of combining the leaf juice with a carrier medium prior to administration.

26. The method of claim 18, wherein Cyclooxygenase-2 is also selectively inhibited, relative to Cyclooxygenase-1.

27. The method of claim 18, wherein the decreasing or prevention of inflammation and/or pain is accomplished while maintaining gastric mucosal integrity.

28. The method of claim 18, further comprising the step of diluting the leaf juice by 100-fold prior to administration.